Dynavax Technologies saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 67 to 85.
When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research reveals that the market's biggest winners often have an 80 or higher RS Rating as they launch their biggest price moves.
Looking For Winning Stocks? Try This Simple Routine
Dynavax Technologies stock is now considered extended and out of buy range after clearing a 10.45 buy point in a first-stage cup with handle. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The company posted -1,150% EPS growth in its most recent report. Sales rose 707%. Look for the next report on or around Feb. 25.
The company earns the No. 68 rank among its peers in the Medical-Biomed/Biotech industry group. Vertex Pharmaceuticals and Innoviva are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
